IDEXX Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 02, 2022 at 06:32 am EDT
Share
IDEXX Laboratories, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 860.55 million compared to USD 826.14 million a year ago. Net income was USD 131.98 million compared to USD 202.58 million a year ago. Basic earnings per share from continuing operations was USD 1.57 compared to USD 2.37 a year ago. Diluted earnings per share from continuing operations was USD 1.56 compared to USD 2.34 a year ago.
For the six months, sales was USD 1,697.1 million compared to USD 1,603.85 million a year ago. Net income was USD 325.94 million compared to USD 406.84 million a year ago. Basic earnings per share from continuing operations was USD 3.87 compared to USD 4.76 a year ago. Diluted earnings per share from continuing operations was USD 3.82 compared to USD 4.69 a year ago.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows:
- veterinary diagnoses for pets (91.6%);
- water quality analysis (4.6%);
- veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products;
- other (0.5%).
Net sales by source of income break down between product sales (57.1%) and services (42.9%).
Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
IDEXX LABORATORIES, INC. 
